REVIEW ARTICLE

A Focused Review on Emerging SARS-Cov-2 Variants

Anagha Renjitha1 Malavika Jayaram1 , # Open Modal Ayisha A. Jabbar1 , # Open Modal Aparna B. Murukan1 , # Open Modal Haripriya Haridasan1 , # Open Modal Akshara Prijikumar1 , # Open Modal Sneha Baiju1 , # Open Modal Adrial Ann Nixon1 , # Open Modal Nihal Najeeb1 , # Open Modal Ponnambil Anantha Krishnan1 , # Open Modal Sunu Rodriguez1 , # Open Modal Bipin G. Nair1 Arya Aloor1 Renuka Suravajhala1 Prashanth Suravajhala1 , * Open Modal Authors Info & Affiliations
The Open COVID Journal 06 June 2023 REVIEW ARTICLE DOI: 10.2174/26669587-v3-2305300-2022-48

Abstract

Over the past 33 months, 10 SARS-CoV-2 mutant variants have evolved. Among them, very few were infectious, while the rest were not that rampantly infectious. As COVID-19 has been the century’s most destructive pandemic, and as the variants of concern and significance are heralding nature, there is an inherent need to bring collaborative convergence among scientists to combat future pandemics such as COVID-19. A question remains whether these emerging variants could allow us to define the advent of pathogenesis and whether or not we are prepared. In this review, we give a gist of variants that could be associated with the recombination events concerned with SAR-CoV-2 that have an impact on the immune response in the human body.

Keywords: COVID-19, Genomics, Variants of concern, SARS-CoV-2, Recombination, Infection.
Fulltext HTML PDF ePub
1800
1801
1802
1803
1804